2017 Annual Meeting | C62 - Mild Cognitive Impairment: Implications for Clinicians
07:00 AM - 08:00 AM | Speaker |
Overview of Mild Cognitive Impairment
Ronald C. Petersen, MD, PhD, FAAN |
08:00 AM - 08:45 AM | Speaker |
Mild Cognitive Impairment: Prediction of Progression and Treatment
David J. Gill, MD, FAAN |
08:45 AM - 09:00 AM | Q&A |
Questions and Answers
|
Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
David J. Gill, MD, FAAN | Dr. Gill has nothing to disclose. |